OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 26, 2023
deCODE genetics, a subsidiary of Amgen, will whole-genome sequence 35,000 African-American samples provided by Illumina and Nashville Biosciences.
The United States Patent and Trademark Office issued a Notice of Allowance for Zika vaccine patent to GeoVax.
January 18, 2023
Recently, 2seventy bio announced the initiation of a strategic partnership with JW Therapeutics aiming at the collaboration being the development of 2seventy bio’s MAGE-A4 cell therapy in mainland China, Hong Kong, and Macao.
Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.
The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.
January 11, 2023
The definitive agreement will give AstraZeneca global rights to CinCor’s portfolio of cardiorenal disease treatments.
Ipsen’s $952 million acquisition of Albireo is designed to bolster the company's rare disease portfolio.
Sartorius and RoosterBio will work together to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.
Messenger RNA is inherently unstable and thus requires unique solutions to protect its cohesion.
January 09, 2023
Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing.